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Abstract Using PCR techniques, we detected a -260 bp (type I) and a -200 bp (type II) tandem duplications inthe mtDNA of muscle biopsies from 
aged individuals. Only one 70-year-old subject was found to harbour the type I and 28 out of 58 subjects had type II duplication. About 90% of 
the subjects harbouring the duplicated mtDNAs also had the 4,977 bp deletion. Moreover, the incidence and quantity of the type II duplication were 
found to increase with age. The proportion of the type II duplicated mtDNA in the muscle of a 71-year-old subject was 3.1% while that of a55-year-old 
individual was only 0.78%. We suggest that the tandem duplications occur alone or with mtDNA deletions in human tissues in an age-dependent 
manner, and thereby cause synergistic deleterious effects on mitochondrial respiratory functions in human ageing. 
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1. Introduction 
Human mitochondrial DNA (mtDNA) is a circular double- 
stranded DNA of 16,569 bp in size [l]. The genome contains 
genes coding for 13 polypeptides involved in respiration and 
oxidative phosphorylation, 2 rRNAs and a set of 22 tRNAs 
that are essential for protein synthesis of the mitochondria [ 11. 
In sharp contrast to the nuclear DNA, mtDNA is a naked 
compact DNA molecule without introns, and is replicated with 
much higher rate without proof-reading and efficient DNA 
repair mechanisms [2-6]. These characteristics have rendered 
mtDNA more vulnerable to attack by reactive oxygen species 
and free radicals that are generated by the electron leak of the 
respiratory chain of mitochondria [7]. 
In the past few years, a number of point mutations, deletions 
and insertions have been found in mtDNA from patients with 
specific neuromuscular diseases [8,9]. Recently, two point mu- 
tations at nucleotide position (np) 3,243 and np 8,344 of 
mtDNA, which are respectively associated with mitochondrial 
myopathy, encephalopathy, lactic acidosis and stroke-like epi- 
sodes syndrome (MELAS) and myoclonic epilepsy and ragged- 
red fibers disease (MERRF), were detected in the muscle 
mtDNA of old humans [lO,l 11. Moreover, several mtDNA 
deletions have also been identified in various tissues of old 
humans [ 12-201. The most common one is the 4,977 bp deletion 
with a 13 bp direct repeat flanking the 5’- and 3’-end break- 
points at np 847018482 and np 13447113459. This deletion was 
originally observed in the muscle of patients with mitochondrial 
myopathies, including the KeamsSayre syndrome (KSS) and 
chronic progressive xternal ophthalmoplegia (CPEO) [21,22]. 
*Corresponding author. Fax: (886) (2) 8264843. 
Abbreviations: PCR, polymerase chain reaction; mtDNA, mitochon- 
drial DNA; np, nucleotide position; MELAS, mitochondrial myopa- 
thy, encephalopathy, lactic idosis and stroke-like pisodes yndrome; 
MERRF, myoclonic epilepsy and ragged-red fibers disease; KSS, 
Keams-Sayre syndrome; CPEO, chronic progressive xternal ophthal- 
moplegia. 
However, the proportions of the age-related mtDNA deletions 
in various tissues of old humans are not so high as those of the 
patients with mitochondrial myopathies that they could not be 
detected by Southern hybridization and are usually detected by 
the polymerase chain reaction (PCR) technique. 
Recently, Brockington et al. [23] reported a heteroplasmic 
tandem duplication with an approximate size of -260 bp in the 
D-loop of human mtDNA and proposed that it is associated 
with large-scale deletions in mtDNAs of patients with mito- 
chondrial myopathies. They further suggested that the dupli- 
cated mtDNA might be responsible for mild mitochondrial 
dysfunction in the muscle of the mothers of some patients, and 
is a predisposition to mtDNA deletions. 
Accumulation of mutations in mtDNA has been recently 
proposed to be the major cause of respiratory function decline 
during human ageing process [24]. On the basis of the observa- 
tions of the existence of disease-associated mutations in the 
mtDNA of old humans, we have investigated if the tandem 
duplicated mtDNA also exists in aged individuals. Interest- 
ingly, we found two types of tandem duplicated mtDNAs: type 
I is identical to the -260 bp duplication, while type II is a novel 
-200 bp partially duplicated mtDNA. The relationship between 
the duplications and the common 4,977 bp deletion in mtDNA 
during human ageing process is discussed. 
2. Materials and methods 
2. I. Preparation of samples 
We obtained 58 muscle biopsies from Chinese subjects of different 
ages in the Veterans General Hospital, Taipei. All the samples were 
obtained with consent of the patients during exploratory laparotomy 
or surgical operations. All the patients were screened by clinical, bio- 
chemical and genetic criteria to exclude the possibility of being associ- 
ated with any of the known mitochondrial diseases. In the genetic 
approach, we had examined all the samples by reported methods [25,26] 
to exclude the np 3,243 A-to-G and np 8,344 A-to-G point mutations 
that are associated with MELAS and MERRF syndromes, respectively. 
Large-scale deletions other than ageing-associated 4,977 bp and 7,436 
bp deletions were also examined by PCR using primers encompassing 
the region between replication origin for heavy strand (Od and that for 
light strand (0,). Total DNA was prepared from the specimens by the 
proteinase K/SDS protocol similar to that described by Sambrook et 
al. [271. 
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2.2. Polymerase chain reaction (PCR) 
Each desired mtDNA fragment was amplified in a 50 ~1 reaction 
medium containing 200 fiM of each dNTPs, 1 unit of Taq DNA polym- 
erase (Perkin-Elm&Ken@, 0.4 PM of each primer, 50-mM K‘Cl,- 1.5 
mM MgCl, and 10 mM Tris-HCl, pH 8.3. The sequences of primers 
were identical to those described by Brockington and coworkers [23]: 
L336, S-AACACATCTCTGCCAAACCC-3’ (np 336-355 of 
mtDNA): L467. 5’-CCCATACTACTAATCTCATC-3’ (nn 467486): 
H335, ?-TAAGTGCTGTGGCCAGAAGC-3’ (np 335-316); and 
H466, 5’-AGTGGGAGGGGAAAATAATG-3’ (np 466447). The 
DNA amplification reactions were carried out for 30 cycles in a Perkin- 
Elmer/Cetus DNA thermal cycler. The first cycle was done by 3 min 
denaturation at 94°C 3 min annealing at 55°C and 1 min extension at 
72°C. The thermal profile of the following PCR cycles was as follows: 
denaturation at 94°C for 40 s, annealing at 55°C for 40 s and extension 
at 72°C for 50 s. 
2.3. DNA sequencing 
The PCR product was treated with the Klenow fragment and then 
cloned by blunt-end ligation to an EcoRV digested pGEM-Szf(-) plas- 
mid (Promega Co., Madison, WI). DNA sequencing was performed 
using the SequiTherm cycle sequencing kit (Epicentre Technologies 
Co., Madison, WI) according to the instructions of the manufacturer. 
2.4. Semi-quantitative PCR 
Total DNA from each muscle biopsy was serially diluted by two fold 
with distilled water. The range of dilution was usually between 2’ to 2**. 
The primers L3108 and H3324 were used to amplify a 236 bp DNA 
fragment from total mtDNA, and the primers L336 and H335 were 
used for the amplification of a -200 bp PCR product from the type II 
duplicated mtDNA. The sequences of the primers L3108 and H3324 
were S-TTCAAATTCCTCCCTGTACG-3’ (np 3108 to 3127 of 
mtDNA) and 5’-TGGGTACAATGAGGAGTAGG-3’ (np 3343 to 
3324), respectively. Amplified DNA fragments were separated by elec- 
trophoresis on 1.5% agarose gels at 100 V for 40 min and were detected 
fluorographically under UV light transillumination after staining with 
ethidium bromide. The proportion of the type II duplicated mtDNA 
was determined by the ratio of the highest dilution fold that allowed 
the -200 bp PCR Product amplified from the type II duplicated mtDNA 
to be visible on the gel to that which allowed the 236 bp PCR product 
to be visibly amplified from the total mtDNA under identical condi- 
tions [19]. 
3. Results 
By the PCR method using primer pairs L336-H335 and 
L467-H466, we first screened for the -260 bp tandem duplica- 
tion in mtDNAs of the muscle biopsies from 58 normal Chinese 
subjects. The ages of the subjects ranged from 1 to 79 years, 
which represent a broad age spectrum. Only one 70-year-old 
subject was found to harbour the -260 bp duplicated mtDNA 
in his muscle. Further, we detected another novel -200 bp tan- 
dem duplication in the D-loop of mtDNA from 28 out of the 
58 subjects. Although the exact size of the novel duplication 
was not known, the length of the PCR fragment amplified from 
the novel duplicated mtDNA was about 200 bp (Fig. 1). The 
PCR products obtained from the two primer pairs were identi- 
cal in size. In a separate experiment by using the primers L467- 
H335, we obtained a less intense -70 bp PCR product from the 
mtDNAs harbouring the -200 bp tandem duplication (data not 
shown). These results indicate that the duplication is authentic 
and that the size is very close to 200 bp. 
By cloning and sequencing, we demonstrated that the se- 
quence of the -260 bp fragment was similar to that reported by 
Brockington et al. [23]. The sequence from np 302 to 447 con- 
tained two additional cytosines (C) near the 5’ end of this 
region, which was inserted at np 567 (Fig. 2). Moreover, we 
found that the sequence of the novel -200 bp fragment was 
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Pig. 1. PCR amplification of the -260 bp and -200 bp tandem duplica- 
tions in the D-loop of mtDNA from muscle biopsies of old humans. (A) 
Two pairs of primers L.3368335 and L467-H466 were used to amplify 
the D-loop sequence of human mtDNA. Since the primers were such 
designed (back to back) that no PCR product could be generated from 
normal mtDNA and only those mtDNA molecules containing the puta- 
tive tandem duplications were amplified to give rise the PCR product 
with a distinct size. (B) The -260 bp PCR products amplified with 
primers L336H335 (lanes 1 and 2) and L467-H466 (lane 3) for 30 
cycles from mtDNAs of muscle biopsies from a 36-year-old subject with 
mitochondrial myopathy (lane 1) and that from a 70-year-old normal 
subject (lanes 2 and 3). Lanes 4 to.6 represent the -200 bp PCR products 
anmlified with mimers L336H335 (lanes 4 and 5) and L467-H466 
(lane 6) from mt’DNAs of the muscle biopsies from two normal subjects 
of 71 (lane 4) and 75 (lanes 5 and 6) years old, respectively. M indicates 
the 100 bp ladder DNA size marker. 
different from that ofthe -260 bp fragment. There were also two 
additional C nucleotides near the 5’ end of the segment from 
np 302 to 447, which was inserted at np 493 of mtDNA (Fig. 
In order to test the hypothesis that tandem duplication is a 
predisposition to the large-scale deletion of mtDNA, we also 
screened for the 4,977 bp deletion in mtDNAs of the muscle 
biopsies from the 58 subjects. The results showed that about 
one-third of the subjects who had the 4,977 bp deletion did not 
harbour the -200 bp tandem duplication and that near 10% of 
the subjects who had the tandem duplication did not carry the 
4,977 bp deletion in their muscles (Table 1). On the other hand, 
we found that the -200 bp tandem duplication occurred more 
frequently and abundantly in subjects of older age groups than 
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Fig. 2. Light strand nucleotide sequence of mtDNA showing the S-end junction of the type I and type II tandem duplications. Type I (left panel) 
duplication of -260 bp was inserted with a junction sequence of ACCCCCCC to the np 567 near the heavy strand promoter region. Type II (right 
panel) duplication, with -200 bp in size, was inserted by an identical AC, sequence to np 493 between the tRNAPhS and heavy strand promoter. The 
additional C residues are marked with asterisks at the end of the poly C run in the inserted duplicated sequence.. 
did in younger subjects (Fig. 3). The frequency of occurrence 
of the type II duplication in mtDNAs of the muscle biopsies 
from 58 subjects was 0% (O/4), 16.7% (l/6), 50% (3/6), 27.3% 
(3/l l), 100% (3/3), 56.3% (9/16) and 75% (9/12) for the subjects 
in the age groups of O-9,10-29,3@-39,4@49,50-59,60-69 and 
70-79, respectively. The youngest subject that was found to 
harbour the type II duplication was 18. The type II duplication 
was not detectable by the two primer pairs in 3 of the 12 
individuals above 70 years of age. However, one of the three 
subjects was found to harbour the -260 bp duplicated mtDNA 
in his muscle biopsies (Table 1). 
Using a semi-quantitative PCR method [19], we determined 
the proportion of the type II duplicated mtDNA from some 
samples that harboured the -200 bp duplication. We found that 
about 3.1% of the type II duplicated mtDNA was present in the 
muscle of a 71-year-old subject, while only about 0.78% of the 
duplicated mtDNA was detected in the muscle of an individual 
of 55 years old. 
4. Discussion 
The D-loop of human mtDNA contains the replication ori- 
gin On and two transcriptional promoters for each strand of 
mtDNA [5]. The replication origin 0, is nested within a cluster 
of five tRNA genes well away from the D-loop. Initiation of 
L-strand synthesis occurs after 0, is exposed as a single- 
stranded template by displacement accompanying the synthesis 
of a nascent H-strand during mtDNA replication. Thus, On is 
the dominant element for initiation of mtDNA replication. On 
the other hand, the promoters in the D-loop region are the only 
established promoters regulating the transcription of human 
mtDNA [28,29]. Therefore, the D-loop is the most important 
control region in human mtDNA. Any types of mutation in the 
regulatory elements in the D-loop of mtDNA can cause altera- 
tions of mitochondrial DNA replication and/or transcription. 
Brockington et al. [23] detected a -260 bp tandem duplicated 
mtDNA in the muscle from some of the patients with mito- 
chondrial myopathies. The duplication results in additional 
copies of conserved sequence blocks (CSB) II and III, and light 
strand and heavy strand promoters. They proposed that the 
duplication may account for a paucity of H strand transcripts 
but normal or slightly increased amounts of L strand tran- 
scripts of mtDNA as detected by in situ hybridization. Moreo- 
ver, they suggested that large-scale mtDNA deletions are asso- 
Table 1 
Coexistence of 4,977 bp deletion and tandem duplications in the D-loop of human muscle mtDNA from Chinese subjects of different ages 
Aee 1 1 6 8 10 10 17 18 18 25 35 35 36 36 38 39 40 41 42 42 42 45 46 46 47 47 49 55 55 
4,977 bp deletion - - - - - - + - + + + + + + - - - - - - + - + + + + + + + 
Type I duplication - _ - - - - _ - _ - _ - - _ - _ - _ _ - _ _ _ _ _ _ _ _ _ 
Tvne II dunlication - - - - - - - - + + - - - + + + - - - + - - - - - + + + + 
Ane 55 60 60 60 60 61 62 64 64 65 65 65 65 66 67 67 68 70 70 70 71 71 71 71 72 74 75 76 79 
4,977 bp deletion + + + + + + + - - - + + + + + + + + + + + + + + + + + + + 
TypeIduplication - _ - - _ - _ _ _ _ _ _ _ _ _ _ - + _ _ _ _ _ _ _ _ _ _ _ 
Type II duplication + - - + + + + - - + - + + - - + + - + + - + + + + + + - + 
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Fig. 3. Age-dependent increase in the incidence and abundance of the -200 bp duplicated mtDNA in human muscle. The -200 bp PCR products were 
amplified with e primer pair L336H335 for 30 cycles from mtDNAs of the muscle biopsies from subjects (lanes 1 to 14) with ages of 1, 8, 35, 
36, 38, 39, 49, 62, 65, 68, 71, 71, 75, and 79, respectively. M indicates the 100 bp ladder DNA size marker. Equal amounts of total DNA from each 
of the muscle biopsies were used for PCR amplification under identical conditions as described in section 2. It is noteworthy that the intensity of 
the -200 bp band increased with the age of the subjects. 
ciated with the heteroplasmic tandem duplications in some pa- 
tients with mitochondrial myopathies and their maternal rela- 
tives. 
In this study, we demonstrated two types of tandem duplica- 
tions in the D-loop of muscle mtDNA from normal subjects of 
different ages (Fig. 1). The incidence and abundance of the type 
II duplication in mtDNAs of the muscle biopsies were found 
to increase with age (Fig. 3). Moreover, quantitative PCR anal- 
ysis indicated that the proportion of the type II duplicated 
mtDNA of older subjects was higher than that of younger ones. 
By contrast, the type I duplication was only detected in the 
muscle of a 70-year-old subject. 
We have reported an age-related increase in the incidence 
and the proportion of the 4,977 bp-deleted mtDNA of the same 
set of muscle biopsies examined in this study [19]. The 4,977 bp 
deletion and the tandem duplications were found to coexist in 
muscle mtDNAs of 60% of the subjects (Table 1). The incidence 
of the 4,977 bp deletion and that of the tandem duplication in 
mtDNA both increased with age. However, it is worth mention- 
ing that 15 subjects that harboured the 4,977 bp-deleted 
mtDNA did not carry either tandem duplications and that 4 
subjects who had the type II duplicated mtDNA did not exhibit 
the 4,977 bp deletion. No clear relationship was found between 
the 4,977 bp deletion and the tandem duplications. 
It is important to note that the two types of tandem duplica- 
tions are inserted at the site with perfect direct repeats of A(C), 
and that the sequence near the 5’junction regions of the dupli- 
cations contained an extra C in the bridging repeat and a 
further C in the polyC run directly downstream from it. The 
number of the extra C flanking this bridging region was noted 
to vary among different old individuals (data not shown). In 
cultured human KB cells, the length variation of the np 302-308 
region has been shown to be due to a homopolymer sequence 
which can range in length from 6 to 12 residues [30]. The 
significance and mechanism causing the additional C nucleo- 
tides in the tandem duplications in the D-loop of mtDNA are 
not clear. 
Accumulation of mtDNA mutations has been proposed to 
be an important contributor to the ageing process of the human 
[24]. A number of point mutations and deletions in mtDNA 
have been established to increase in an age-dependent manner 
in old humans [8,10,11]. In this study, the type II tandem dupli- 
cation in the D-loop of mtDNA was detected in the muscle 
tissues of a number of clinically normal old individuals. There 
may exist other types of duplications in addition to these well- 
characterized mtDNA mutations in human ageing. These mu- 
tations, existing alone or in combinations, will cause synergistic 
deleterious effects on mitochondrial respiration and oxidative 
phosphorylation. This may account, at least in part, for the 
well-documented age-dependent decline of human bioenergetic 
functions. In conclusion, our results support the hypothesis 
that accumulation of mtDNA mutations in tissue cells is a 
contributory factor in the ageing process of the human. 
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